DNA/RNA Sample Extraction and Isolation Market Size is valued at USD 2.33 Bn in 2022 and is predicted to reach USD 4.14 Bn by the year 2031 at a 6.68% CAGR during the forecast period for 2023-2031.
The extraction and isolation of DNA/RNA samples are critical operations in molecular biology and genetics research. They involve the extraction of nucleic acids (DNA and RNA) from cells, tissues, or biological fluids for use in PCR, sequencing, genotyping, gene expression studies, and molecular diagnostics. The DNA/RNA sample extraction and isolation market is dynamic, with numerous variables driving its growth, technological advancements, and adoption. The expanding landscape of genome research, diagnostics, and personalized treatment shapes these market dynamics. The growing use of genomic medicine and personalized medicines involves the collection of high-quality DNA/RNA samples. To support their investigations and therapies, researchers and doctors demand effective extraction procedures.
However, the COVID-19 pandemic had a short-term impact on the DNA/RNA extraction kit market due to constraints on various commercial and research operations. Furthermore, the diagnostics tests for medical disorders and other diseases at hospitals and other diagnostics facilities were impacted due to a reduction in patient turnout for tests as a result of COVID-19.
Competitive Landscape
Some Major Key Players In The DNA/RNA Sample Extraction and Isolation Market:
- Abnova Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd
- Illumina, Inc.
- MACHEREY-NAGEL GmbH & Co. KG
- Merck KGaA
- Norgen Biotek Corp.
- Omega Bio-tek, Inc.
- Promega Corporation
- QIAGEN N.V.
- Tecan Group
- Thermo Fisher Scientific, Inc.
- Zymo Research
- Others
Market Segmentation:
The DNA/RNA Sample Extraction and Isolation Market is categorised on the basis of product, technology, application, and end-user. The product segment includes Consumables (Kits and Reagents) and Instruments. Kits subsegment includes DNA kits like Cell-free DNA, Genomic DNA, Microbe DNA, Plasmid DNA, Viral DNA. Whereas RNA kits include Cell-free RNA, Genomic RNA, Microbe RNA and Viral RNA.
The technology segment includes Consumable-Based Technology (Silica-Based, Magnetic Particle Technology, and Other Technologies) and Instrument-Based Technology (Automated Spin Column-Based, Magnetic Bead-Based, and Automated Liquid Handling). By application, the market is segmented into PCR, NGS, Cloning, Microarray, Blotting Techniques, and Other Applications. The end-user segment includes Clinical Diagnostic and Forensic Laboratories, Research Academics and Institutions, Pharmaceutical and Biotechnology companies, Contract Research Organizations, and Others.
Based On Product, The Consumables Segment Is A Major Contributor In The DNA/RNA Sample Extraction And Isolation Market.
The Consumables category is expected to hold a major share of the global DNA/RNA Sample Extraction and Isolation Market in 2022. The consumables market for DNA/RNA sample extraction and isolation encompasses a diverse range of goods and kits required for the effective and consistent extraction and purification of nucleic acids. Consumables are the most common product type since they are used in practically all applications related to the worldwide DNA/RNA sample extraction and isolation market. Due to the increasing utilization of media, kits, and reagents, it is anticipated that this segment will continue to grow significantly in the forecasting period.
The PCR Segment Witnessed Growth At A Rapid Rate.
The PCR segment is projected to grow at a rapid rate in the global DNA/RNA Sample Extraction and Isolation Market. The market for DNA/RNA sample extraction and isolation for PCR applications is a critical part of the molecular diagnostics industry. The dynamics of this market are impacted by a number of factors, including the increased demand for dependable nucleic acid extraction methods for polymerase chain reaction (PCR) analysis. PCR is commonly used in many laboratories worldwide because it further amplifies DNA, allowing the examination of even extremely minute amounts of nucleic acid. PCR has been used in various domains, including illness detection, DNA profiling, precision medicine, and gene expression, as molecular biology techniques have advanced.
In The Region, The Asia Pacific DNA/RNA Sample Extraction And Isolation Market Holds A Significant Revenue Share.
The Asia Pacific DNA/RNA Sample Extraction and Isolation Market is expected to record the maximum market revenue share in the near future owing to rising demand for molecular diagnostics, genomics research, and an increase in infectious diseases. Due to massive R&D expenditure by the government and corporate entities, increasing demand for kits, and rising occurence of chronic diseases such as cancer, the United States is predicted to dominate the region's DNA/RNA extraction kit market.
Recent Developments:
- In July 2023, QIAGEN announced the release of the QIAseq Normalizer Kits, which provide researchers with a quick, easy, and cost-effective way to pool various DNA libraries for the best-quality results from next-generation sequencing (NGS) runs. The QIAseq Normalizer Kit reduces the time required to normalize DNA concentrations across NGS libraries from several hours to 30 minutes.
- In March 2021, Tecan and Zymo Research collaborated on forces to create a ready-to-use processing system that makes it easier to get viral DNA and RNA from nasopharyngeal swabs, oropharyngeal swabs, saliva, sputum, plasma, and serum. The Zymo Research Quick-DNA/RNA™ Viral MagBead Kit on the DreamPrep NAP workstation made the process easier by pre-loading scripts that were tuned for viral RNA extraction and were being tested for COVID-19 assays by high-complexity testing labs
DNA/RNA Sample Extraction and Isolation Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 2.33 Bn |
|
Revenue Forecast In 2031 |
USD 4.14 Bn |
|
Growth Rate CAGR |
CAGR of 6.68% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Technology, Application, End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Abnova Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., MACHEREY-NAGEL GmbH & Co. KG, Merck KGaA, Norgen Biotek Corp., Omega Bio-tek, Inc., Promega Corporation, QIAGEN N.V., Tecan Group, Thermo Fisher Scientific, Inc., and Zymo Research. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
